AUC	area under the receiver operating characteristic curve
DR	dissociated response
GEE	generalized estimating equation
HPD	hyperprogressive disease
ICI	immune checkpoint inhibitor
iRECIST	modified RECIST 1.1 for immune-based therapeutics
irRC	immune-related response criteria
irRECIST	immune-related RECIST
NSCLC	non-small cell lung cancer
OS	overall survival
PD	progressive disease
PD-1	receptor programmed cell death 1
PD-L1	programmed death ligand 1
PR	partial response
ROC	receiver operating characteristic
SD	stable disease
TGK	tumor growth kinetics